{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:54:46Z","timestamp":1782316486239,"version":"3.54.5"},"reference-count":34,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"unspecified","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"NIHR advanced fellowship","award":["NIHR302478"],"award-info":[{"award-number":["NIHR302478"]}]},{"DOI":"10.13039\/100011700","name":"Crohn\u2019s in Childhood Research Association","doi-asserted-by":"publisher","award":["Grant no- NA"],"award-info":[{"award-number":["Grant no- NA"]}],"id":[{"id":"10.13039\/100011700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2026,5,15]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the relationship between anti-tumour necrosis factor (TNF) use and surgical resection rates in a regional paediatric inflammatory bowel disease (IBD) cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study used prospectively maintained electronic data from a regional UK paediatric gastroenterology centre (2007\u20132024). Included were individuals with modified Porto IBD diagnosis, aged \u226417 years. Annual prevalent IBD population was estimated using incident diagnoses and transition to adult services. Abdominal surgery rates (strictureplasty, resection, primary stoma) and anti-TNF administration were collected and prevalence calculated. Three anti-TNF epochs, defined by the European Crohn\u2019s and Colitis Organisation\/European Society of Paediatric Gastroenterology, Hepatology and Nutrition guidelines in 2014 and 2020, were compared: Epoch-1 (2007\u20132013; &lt;20% anti-TNF), Epoch-2 (2014\u20132020; 20%\u201350%) and Epoch-3 (2021\u20132024; &gt;50%). Kaplan\u2013Meier analysis with log-rank testing compared surgery-free survival between early and later anti-TNF treatment groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One thousand five hundred and thirty-eight children were included (915 Crohn\u2019s disease (CD), 529 ulcerative colitis (UC) and 94 IBD-unclassified). Median age at diagnosis was 13.3 years, and the prevalent population increased (253\u2013597 patients). Anti-TNF-treated prevalence rose across epochs (5.9%, 31.9%, 61.1%; p&lt;0.001). Resection rates declined 3.93%, 1.57% and 1.09% (Epoch 1\u20133) (p=0.003). Rates did not significantly decrease from Epoch 2 to 3 (p=0.217). CD surgery significantly decreased (4.9%, 1.7%, 1.5%, p=0.006); trends in UC rates did not reach significance (1.89%, 1.55%, 0.56%, p=0.314). Time to anti-TNF from diagnosis decreased (1.2, 0.8 and 0.26 years, p=0.008). Early vs later anti-TNF initiation was not associated with surgery-free survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We report a significant increase in anti-TNF prevalence, with earlier deployment. Surgical resection rates have declined and plateaued; reflecting reduced CD surgery. Future research should focus on optimised anti-TNF and second-line biologic deployment to move beyond current levels of surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgast-2026-002344","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:40:20Z","timestamp":1782315620000},"page":"e002344","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Escalating anti-tumour necrosis factor exposure with reductions in surgical resection rates in paediatric inflammatory bowel disease: an 18-year real-world population-based cohort study"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2907-5538","authenticated-orcid":false,"given":"Zachary","family":"Green","sequence":"first","affiliation":[{"name":"Department of Human Genetics and Genomic Medicine, University of Southampton, Southampton, UK"},{"name":"Department of Paediatric Gastroenterology, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrna","family":"Nicholas","sequence":"additional","affiliation":[{"name":"Department of Paediatric Gastroenterology, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Vuijk","sequence":"additional","affiliation":[{"name":"Department of Paediatric Gastroenterology, Erasmus MC Sophia, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Stanton","sequence":"additional","affiliation":[{"name":"Department of Paediatric Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bakewell","sequence":"additional","affiliation":[{"name":"Department of Paediatric Gastroenterology, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Coelho","sequence":"additional","affiliation":[{"name":"Department of Paediatric Gastroenterology, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Batra","sequence":"additional","affiliation":[{"name":"Department of Paediatric Gastroenterology, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem A","family":"Afzal","sequence":"additional","affiliation":[{"name":"Department of Paediatric Gastroenterology, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ennis","sequence":"additional","affiliation":[{"name":"Department of Human Genetics and Genomic Medicine, University of Southampton, Southampton, UK"},{"name":"Southampton Biomedical Research Centre, NIHR, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Mark","family":"Beattie","sequence":"additional","affiliation":[{"name":"Department of Paediatric Gastroenterology, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0348-8198","authenticated-orcid":false,"given":"James","family":"Ashton","sequence":"additional","affiliation":[{"name":"Department of Human Genetics and Genomic Medicine, University of Southampton, Southampton, UK"},{"name":"Department of Paediatric Gastroenterology, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"2026062408401111000_13.1.e002344.1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.21037\/tp.2018.12.03","article-title":"Personalising medicine in inflammatory bowel disease-current and future perspectives","volume":"8","author":"Ashton","year":"2019","journal-title":"Transl Pediatr"},{"key":"2026062408401111000_13.1.e002344.2","doi-asserted-by":"crossref","first-page":"ii31","DOI":"10.1093\/ecco-jcc\/jjae087","article-title":"Considerations in Paediatric and Adolescent Inflammatory Bowel Disease","volume":"18","author":"Vuijk","year":"2024","journal-title":"J Crohns Colitis"},{"key":"2026062408401111000_13.1.e002344.3","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2024-102940"},{"key":"2026062408401111000_13.1.e002344.4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.dld.2023.04.017","article-title":"Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study","volume":"56","author":"Fumery","year":"2024","journal-title":"Dig Liver Dis"},{"key":"2026062408401111000_13.1.e002344.5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/apt.15094","article-title":"Increased prevalence of anti-TNF therapy in paediatric inflammatory bowel disease is associated with a decline in surgical resections during childhood","volume":"49","author":"Ashton","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2026062408401111000_13.1.e002344.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.04.005"},{"key":"2026062408401111000_13.1.e002344.7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjaa161","article-title":"The Medical Management of Paediatric Crohn\u2019s Disease: an ECCO-ESPGHAN Guideline Update","volume":"15","author":"van Rheenen","year":"2021","journal-title":"J Crohns Colitis"},{"key":"2026062408401111000_13.1.e002344.8","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3182662233"},{"key":"2026062408401111000_13.1.e002344.9","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000002035"},{"key":"2026062408401111000_13.1.e002344.10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S2468-1253(24)00044-X","article-title":"Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn\u2019s disease: 3-year data from the prospective, multicentre PANTS cohort study","volume":"9","author":"Chanchlani","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026062408401111000_13.1.e002344.11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MPG.0000000000003643","article-title":"Adalimumab Therapy in Pediatric Crohn Disease","volume":"76","author":"Payen","year":"2023","journal-title":"J pediatr gastroenterol nutr"},{"key":"2026062408401111000_13.1.e002344.12","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000000239"},{"key":"2026062408401111000_13.1.e002344.13","doi-asserted-by":"publisher","DOI":"10.1097\/01.MPG.0000163736.30261.82"},{"key":"2026062408401111000_13.1.e002344.14","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.187120"},{"key":"2026062408401111000_13.1.e002344.15","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13363"},{"key":"2026062408401111000_13.1.e002344.16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ecco-jcc\/jjad197","article-title":"Improved Clinical Outcomes With Early Anti-Tumour Necrosis Factor Alpha Therapy in Children With Newly Diagnosed Crohn\u2019s Disease: Real-world Data from the International Prospective PIBD-SETQuality Inception Cohort Study","volume":"18","author":"Klomberg","year":"2024","journal-title":"J Crohns Colitis"},{"key":"2026062408401111000_13.1.e002344.17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5217\/ir.2018.16.1.62","article-title":"Comparison of time until elective intestinal resection regarding previous anti-tumor necrosis factor exposure: a Brazilian study on patients with Crohn\u2019s disease","volume":"16","author":"Kotze","year":"2018","journal-title":"Intest Res"},{"key":"2026062408401111000_13.1.e002344.18","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305607"},{"key":"2026062408401111000_13.1.e002344.19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S2468-1253(17)30248-0","article-title":"Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn\u2019s disease: a randomised controlled, open-label, multicentre trial","volume":"2","author":"Ponsioen","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026062408401111000_13.1.e002344.20","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/ecco-jcc\/jjaa044","article-title":"Temporal Trends in Surgical Resection Rates and Biologic Prescribing in Crohn\u2019s Disease: A Population-based Cohort Study","volume":"14","author":"Jenkinson","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2026062408401111000_13.1.e002344.21","first-page":"420","article-title":"Prevalence, incidence, and treatment patterns of fistulizing Crohn disease: A US population-based cohort study","volume":"30","author":"Fan","year":"2024","journal-title":"J Manag Care Spec Pharm"},{"key":"2026062408401111000_13.1.e002344.22","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-305214"},{"key":"2026062408401111000_13.1.e002344.23","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izad302"},{"key":"2026062408401111000_13.1.e002344.24","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.12.282"},{"key":"2026062408401111000_13.1.e002344.25","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14430"},{"key":"2026062408401111000_13.1.e002344.26","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/apt.17217","article-title":"The inexorable increase of biologic exposure in paediatric inflammatory bowel disease: a Scottish, population-based, longitudinal study","volume":"56","author":"Burgess","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2026062408401111000_13.1.e002344.27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.cgh.2024.06.049","article-title":"The Cost of Inflammatory Bowel Disease Care: How to Make it Sustainable","volume":"23","author":"Burisch","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026062408401111000_13.1.e002344.28","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/17474124.2019.1685872","article-title":"Inflammatory bowel disease: long-term therapeutic challenges","volume":"13","author":"Ashton","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2026062408401111000_13.1.e002344.29","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.21037\/tp-23-210","article-title":"Recent developments in the assessment and management of inflammatory bowel disease in childhood: a narrative review","volume":"12","author":"Green","year":"2023","journal-title":"Transl Pediatr"},{"key":"2026062408401111000_13.1.e002344.30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/ecco-jcc\/jjac135","article-title":"Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents","volume":"17","author":"Croft","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2026062408401111000_13.1.e002344.31","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000002036"},{"key":"2026062408401111000_13.1.e002344.32","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/jpn3.70096","article-title":"Management of paediatric ulcerative colitis, part 2: Acute severe colitis\u2014An updated evidence\u2010based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn\u2019s and Colitis Organization","volume":"81","author":"Assa","year":"2025","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2026062408401111000_13.1.e002344.33","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2023-102419"},{"key":"2026062408401111000_13.1.e002344.34","doi-asserted-by":"crossref","DOI":"10.1007\/s00384-024-04634-7","article-title":"The need for surgery in pediatric patients with inflammatory bowel disease treated with biologicals","volume":"39","author":"Kolho","year":"2024","journal-title":"Int J Colorectal Dis"}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2026-002344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:40:23Z","timestamp":1782315623000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2026-002344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6,24]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/bmjgast-2026-002344"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2026-002344","relation":{},"ISSN":["2054-4774"],"issn-type":[{"value":"2054-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}